$-4.27
(Market cap
$94,623 Mln
Revenue (TTM)
$403,430 Mln
P/E Ratio
20.5
P/B Ratio
5
Div. Yield
0.4 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$4,762 Mln
-
ROE
0 %
-
ROCE
78.5 %
-
Industry P/E
--
-
EV/EBITDA
13.9
-
Debt to Equity
-4
-
Book Value
$--
-
EPS
$38.8
-
Face value
--
-
Shares outstanding
120,204,051
10 Years Aggregate
CFO
$41,554.00 Mln
EBITDA
$40,794.00 Mln
Net Profit
$11,403.00 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
McKesson (MCK)
| -4.9 | 4.4 | -17.1 | 7.1 | 25.8 | 32.2 | 15.7 |
|
BSE Sensex*
| -9.5 | 1.8 | 2.8 | -5.5 | 6.8 | 7.7 | 11.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
McKesson (MCK)
| 43.9 | 22.9 | 23.4 | 50.9 | 42.9 | 25.7 | 25.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
McKesson (MCK)
|
779.8 | 94,623.4 | 403,430.0 | 4,762.0 | 1.6 | -246.4 | 20.5 | 5.0 |
| 350.5 | 191,704.4 | 37,238.0 | 7,800.0 | 31.7 | 82.9 | 24.7 | 20.9 | |
| 198.6 | 29,534.8 | 9,857.4 | 1,372.4 | 18.4 | 7.4 | 21.5 | 1.6 | |
| 56.2 | 116,663.5 | 48,482.0 | 7,275.0 | 21.6 | 37.7 | 16 | 5.8 | |
| 226.4 | 52,427.0 | 250,549.0 | 1,559.0 | 0.9 | -- | 34.1 | 16.1 | |
| 124.3 | 155,928.8 | 29,734.0 | 9,216.0 | 39.5 | 40.9 | 17.1 | 6.6 | |
| 114.9 | 298,256.0 | 65,593.0 | 8,935.0 | 24.7 | 18.3 | 34 | 6.4 | |
| 151.6 | 293,693.5 | 56,053.0 | 13,533.8 | 30.3 | 32.7 | 22.1 | 7.6 | |
| 26.0 | 149,154.5 | 63,315.0 | 7,491.0 | 16.7 | 8.1 | 20 | 1.6 | |
| 80.0 | 33,358.0 | 9,509.0 | 2,643.0 | 37.3 | 61.2 | 13 | 10.3 |
Shareholding Pattern
View DetailsAbout McKesson (MCK)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical... Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. Read more
-
CEO & Director
Mr. Brian S. Tyler Ph.D.
-
CEO & Director
Mr. Brian S. Tyler Ph.D.
-
Headquarters
Irving, TX
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for McKesson (MCK)
What is the current share price of McKesson Corporation (MCK) Today?
The share price of McKesson Corporation (MCK) is $779.78 (NYSE) as of 15-Jun-2026 16:25 EDT. McKesson Corporation (MCK) has given a return of 25.85% in the last 3 years.
What is the current PB & PE ratio of McKesson Corporation (MCK)?
The P/E ratio of McKesson Corporation (MCK) is 20.49 times as on 12-Jun-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
22.30
|
-48.89
|
|
2025
|
25.71
|
-50.02
|
|
2024
|
23.53
|
-44.18
|
|
2023
|
13.80
|
-32.98
|
|
2022
|
41.00
|
-25.49
|
What is the 52 Week High and Low of McKesson Corporation (MCK)?
The 52-week high and low of McKesson Corporation (MCK) are Rs 999.00 and Rs 637.00 as of 16-Jun-2026.
What is the market cap of McKesson Corporation (MCK)?
McKesson Corporation (MCK) has a market capitalisation of $ 94,623 Mln as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in McKesson Corporation (MCK)?
Before investing in McKesson Corporation (MCK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.